A Case-Control Study of Real-Life Experience with Ceftolozane-Tazobactam in Patients with Hematologic Malignancy and Pseudomonas aeruginosa Infection | Zendy

Ana FernándezCruz | Zendy; Natalia Alba | Zendy; María Auxiliadora Semiglia-Chong | Zendy; Belén Padilla | Zendy; Gabriela RodríguezMacías | Zendy; Mi Kwon | Zendy; Emilia Cercenado | Zendy; Esther ChamorrodeVega | Zendy; Marina Machado | Zendy; Laura PérezLago | Zendy; Darı́o Garcı́a de Viedma | Zendy; José L. DíezMartín | Zendy; Patricia Muñóz | Zendy

Open Access

A Case-Control Study of Real-Life Experience with Ceftolozane-Tazobactam in Patients with Hematologic Malignancy and Pseudomonas aeruginosa Infection

Author(s) -

Ana FernándezCruz,

Natalia Alba,

María Auxiliadora Semiglia-Chong,

Belén Padilla,

Gabriela RodríguezMacías,

Mi Kwon,

Emilia Cercenado,

Esther ChamorrodeVega,

Marina Machado,

Laura PérezLago,

Darı́o Garcı́a de Viedma,

José L. DíezMartín,

Patricia Muñóz

Publication year - 2018

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.02340-18

Subject(s) - hematologic malignancy , pseudomonas aeruginosa , medicine , malignancy , tazobactam , hematologic disease , biology , bacteria , piperacillin , disease , genetics

We present our experience in patients with hematologic malignancy andPseudomonas aeruginosa infection treated with ceftolozane-tazobactam. We performed a single-center case-control study comparing patients with hematologic malignancy andP. aeruginosa infection treated with ceftolozane-tazobactam (study group) with similar patients not treated with ceftolozane-tazobactam (control group) to assess safety and efficacy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research